Mark Covid’s treatment pill wins FDA panel award
Clinical trials have reduced the risk of hospitalization or death by 30% for the most vulnerable and unvaccinated volunteers within five days of the onset of symptoms. It seems to be much less effective than Pfizer’s pill, which has been shown to reduce the risk by 89%. Monoclonal antibody treatments have been shown to reduce … Read more